Cardiovascular consequences of sleep-related breathing disorders.
Sleep-related breathing disorders (SRBDs) represent a spectrum of abnormalities that range from simple snoring to upper airway resistance syndrome to sleep apnea. The clinical presentation may include obesity, snoring, neuropsychological dysfunction, and daytime hypersomnolence and tiredness. The acute hemodynamic alterations of obstructive sleep apnea include systemic and pulmonary hypertension, increased right and left ventricular afterload, and increased cardiac output. Earlier reports attributed the coexistence of SRBDs with cardiovascular diseases to the shared risk factors such as age, sex, and obesity. However, recent epidemiologic data confirm an independent association between SRBDs and the different manifestations of cardiovascular diseases. Possible mechanisms may include a combination of intermittent hypoxia and hypercapnia, repeated arousals, sustained increase in sympathetic tone, reduced baroreflex sensitivity, increased platelet aggregation, and elevated plasma fibrinogen and homocysteine levels. The strength of the association, its pathogenesis, and the impact of treatment of SRBDs on the health outcome of patients with cardiovascular diseases are issues to be addressed in future studies.
D002318:Cardiovascular Diseases / Q000209:etiology; D002319:Cardiovascular System / Q000503:physiopathology*; D002561:Cerebrovascular Disorders / Q000209:etiology; D003326:Coronary Circulation / Q000502:physiology; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology; D012890:Sleep / Q000502:physiology; D012891:Sleep Apnea Syndromes / Q000150:complications* / Q000503:physiopathology*; D013564:Sympathetic Nervous System / Q000502:physiology; D013909:Thorax / Q000502:physiology